Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998815478> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2998815478 abstract "Abstract Background The development of anti-TNFα immunotherapies has led to great advances in quality of life for Crohn’s and colitis patients and has allowed a reduction in steroid use for these diseases. However, a significant proportion of IBD patients is resistant to anti-TNFα agents, or becomes resistant to such treatments over time. Preclinical research and clinical trials have suggested that CCR9 antagonism can effectively reduce colon inflammation. CCR9 is expressed on a subset of T cells dedicated to monitoring the immune status of the intestine. When activated by its only known chemokine ligand, CCL25/TECK, CCR9 triggers the adhesion of gut-specific T cells to vascular endothelium and the subsequent ingress of these cells to intestinal tissues. Antagonism of this receptor inhibits the accumulation of T cells within inflamed intestinal epithelium and lamina propria. Since anti-TNFα and CCR9 antagonists act through entirely different mechanisms, we asked whether these two approaches might synergise and expand the effectiveness and scope of each therapy. Methods We used a piroxicam-accelerated version of the MDR1a−/− spontaneous colitis model in mice. In this model, 7week MDR1a−/− mice (or WT FVB controls) receive piroxicam in powdered chow for 10 days. Mice are monitored both during and after the piroxicam feeding period, for a total of 21 days. Treatment groups (eight mice each) include an antibody (a saturating dose of either anti-TNFα or its isotype-matched control) and a CCR9 antagonist (or its vehicle alone as a control). Body weight and diarrhoea score were recorded throughout the entire 21 days period, after which colons were obtained from sacrificed animals for weighing, length measurement and imaging. Results We have found that combined dosing of piroxicam-fed MDR1a−/− mice with a CCR9 antagonist and an anti-TNFα MAb significantly reverses loss of body weight, diarrhoea score and colon inflammation. The combined dosing was more effective than anti-TNFα or CCR9 antagonist alone, as measured by colon length/weight ratio, neutrophil accumulation in the colonic epithelium and reversal of the loss in body weight characteristic of this model. Conclusion These data suggest that combining a CCR9 antagonist with existing anti-TNFα treatment regimens may extend the benefits of anti-TNFα immunotherapy to a larger class of patients suffering from IBD and may prolong the effectiveness of anti-TNFα immunotherapy for those patients already undergoing such treatments." @default.
- W2998815478 created "2020-01-23" @default.
- W2998815478 creator A5015188737 @default.
- W2998815478 creator A5015756622 @default.
- W2998815478 creator A5054580277 @default.
- W2998815478 creator A5055939902 @default.
- W2998815478 creator A5062783434 @default.
- W2998815478 creator A5075926917 @default.
- W2998815478 creator A5078844354 @default.
- W2998815478 creator A5082488310 @default.
- W2998815478 date "2020-01-01" @default.
- W2998815478 modified "2023-09-23" @default.
- W2998815478 title "P037 Antagonism of chemokine receptor CCR9 synergises with anti-TNFα immunotherapy to reduce inflammation in the MDR1a−/− mouse model of colitis" @default.
- W2998815478 doi "https://doi.org/10.1093/ecco-jcc/jjz203.166" @default.
- W2998815478 hasPublicationYear "2020" @default.
- W2998815478 type Work @default.
- W2998815478 sameAs 2998815478 @default.
- W2998815478 citedByCount "0" @default.
- W2998815478 crossrefType "journal-article" @default.
- W2998815478 hasAuthorship W2998815478A5015188737 @default.
- W2998815478 hasAuthorship W2998815478A5015756622 @default.
- W2998815478 hasAuthorship W2998815478A5054580277 @default.
- W2998815478 hasAuthorship W2998815478A5055939902 @default.
- W2998815478 hasAuthorship W2998815478A5062783434 @default.
- W2998815478 hasAuthorship W2998815478A5075926917 @default.
- W2998815478 hasAuthorship W2998815478A5078844354 @default.
- W2998815478 hasAuthorship W2998815478A5082488310 @default.
- W2998815478 hasBestOaLocation W29988154781 @default.
- W2998815478 hasConcept C12823836 @default.
- W2998815478 hasConcept C128879288 @default.
- W2998815478 hasConcept C13373296 @default.
- W2998815478 hasConcept C142724271 @default.
- W2998815478 hasConcept C143172330 @default.
- W2998815478 hasConcept C17991360 @default.
- W2998815478 hasConcept C203014093 @default.
- W2998815478 hasConcept C204787440 @default.
- W2998815478 hasConcept C2775862500 @default.
- W2998815478 hasConcept C2776914184 @default.
- W2998815478 hasConcept C2777310793 @default.
- W2998815478 hasConcept C2778139025 @default.
- W2998815478 hasConcept C529295009 @default.
- W2998815478 hasConcept C71924100 @default.
- W2998815478 hasConcept C8891405 @default.
- W2998815478 hasConcept C98274493 @default.
- W2998815478 hasConceptScore W2998815478C12823836 @default.
- W2998815478 hasConceptScore W2998815478C128879288 @default.
- W2998815478 hasConceptScore W2998815478C13373296 @default.
- W2998815478 hasConceptScore W2998815478C142724271 @default.
- W2998815478 hasConceptScore W2998815478C143172330 @default.
- W2998815478 hasConceptScore W2998815478C17991360 @default.
- W2998815478 hasConceptScore W2998815478C203014093 @default.
- W2998815478 hasConceptScore W2998815478C204787440 @default.
- W2998815478 hasConceptScore W2998815478C2775862500 @default.
- W2998815478 hasConceptScore W2998815478C2776914184 @default.
- W2998815478 hasConceptScore W2998815478C2777310793 @default.
- W2998815478 hasConceptScore W2998815478C2778139025 @default.
- W2998815478 hasConceptScore W2998815478C529295009 @default.
- W2998815478 hasConceptScore W2998815478C71924100 @default.
- W2998815478 hasConceptScore W2998815478C8891405 @default.
- W2998815478 hasConceptScore W2998815478C98274493 @default.
- W2998815478 hasLocation W29988154781 @default.
- W2998815478 hasOpenAccess W2998815478 @default.
- W2998815478 hasPrimaryLocation W29988154781 @default.
- W2998815478 hasRelatedWork W10698364 @default.
- W2998815478 hasRelatedWork W11082109 @default.
- W2998815478 hasRelatedWork W14289313 @default.
- W2998815478 hasRelatedWork W14687542 @default.
- W2998815478 hasRelatedWork W15261138 @default.
- W2998815478 hasRelatedWork W15708667 @default.
- W2998815478 hasRelatedWork W17881900 @default.
- W2998815478 hasRelatedWork W19435201 @default.
- W2998815478 hasRelatedWork W6123347 @default.
- W2998815478 hasRelatedWork W8739995 @default.
- W2998815478 isParatext "false" @default.
- W2998815478 isRetracted "false" @default.
- W2998815478 magId "2998815478" @default.
- W2998815478 workType "article" @default.